Primary Care Based Integrated Community Care Team Intervention
NCT04819256 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2022-04-28
Summary
PACE-It study is a non-blinded, mix-method randomized controlled trial within a single site. This study aims to test the feasibility of implementing a complex intervention comprising of a) a Primary Care Based integrated community care team delivery of person centered care, b) supported by a care co-ordination platform using a mobile application and its effectiveness in improving the glycemic control of patients living with Diabetes and have complex needs.
Conditions
- Diabetes
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetes type2
Interventions
- OTHER
-
PACE-It mobile application
Care co-ordination platform
Sponsors & Collaborators
-
Ministry of Health, Singapore
collaborator OTHER_GOV -
Agency for Integrated Care, Singapore
collaborator OTHER -
SingHealth Regional Health System
collaborator UNKNOWN -
SingHealth Polyclinics
lead OTHER
Principal Investigators
-
Sinead Zhen Wang, Dr · SingHealth Polyclinics
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-07
- Primary Completion
- 2022-02-08
- Completion
- 2022-02-08
Countries
- Singapore
Study Locations
More Related Trials
-
Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients
NCT00819325 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
NCT01095666 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Insulin Peglispro in Healthy Male Japanese Participants
NCT01995526 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus
NCT00661921 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Randomized Controlled Trial of Patient-Centered Self-Management Intervention in Adults With Type 2 Diabetes Mellitus
NCT05491252 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
NCT05680155 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes
NCT00857558 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
NCT02477969 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes
NCT02964572 ·Status: COMPLETED ·Phase: NA
-
Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus
NCT00286494 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
NCT00957268 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus
NCT00286442 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)
NCT00015626 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of MCI-196 in Patients With Type 2 Diabetes
NCT00497198 ·Status: COMPLETED ·Phase: PHASE2
-
Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects
NCT01755442 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus
NCT00263276 ·Status: COMPLETED ·Phase: PHASE2
-
GLucose Monitoring Programme SingaporE, Phase 2 (GLiMPSE2)
NCT04564911 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin
NCT05504226 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 Patients
NCT02477865 ·Status: UNKNOWN ·Phase: PHASE3
-
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients
NCT00972244 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus
NCT01294423 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes
NCT00286455 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
NCT01095653 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy
NCT00515632 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy Subjects
NCT05172622 ·Status: UNKNOWN ·Phase: PHASE1